Role of Akt1 in renal fibrosis and tubular dedifferentiation during the progression of acute kidney injury to chronic kidney disease
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: Acute kidney injury (AKI) is an underestimated yet important risk factor for the development of chronic kidney disease (CKD), characterized by tubulointerstitial fibrosis and tubular dedifferentiation. Tubular dedifferentiation, which is associated with the loss of epithelial markers and the gain of mesenchymal features, is thought to be involved in tubulointerstitial fibrosis. As protein kinase B/Akt is involved in the development of CKD, we investigated the role of Akt1, one of the three Akt isoforms, in a murine model of AKI-to-CKD progression. Methods: We subjected C57BL/6 male mice to unilateral ischemia-reperfusion injury (UIRI) and harvested their kidneys after 6 weeks. Mice were divided into four groups, namely, wild-type (WT) UIRI, Akt1−/− UIRI, WT sham, and Akt1−/− sham. Results: Akt1 (but not Akt2 or Akt3) was markedly activated in WT UIRI mice than in WT sham mice. Tubulointerstitial fibrosis and tubular dedifferentiation significantly increased in WT UIRI mice, but were attenuated in Akt1−/− UIRI mice. Both WT UIRI and Akt1−/− UIRI mice showed markedly upregulated transforming growth factor-β1 (TGF-β1)/Smad signaling compared with WT sham mice. However, TGF-β1/Smad expression did not differ between the two groups. The levels of phosphorylated GSK-3β, β-catenin, and Snail were attenuated in Akt1−/− UIRI mice compared with those in WT UIRI mice. Conclusions: Deletion of Akt1 results in the attenuation of renal fibrosis and tubular dedifferentiation, independent of TGF-β1/Smad signaling, during AKI-to- CKD progression in a UIRI without contralateral nephrectomy model. Thus, Akt1 may serve as a therapeutic target in AKI-to-CKD progression.
Abstract
Background/Aims: Acute kidney injury (AKI) is an underestimated yet important risk factor for the development of chronic kidney disease (CKD), characterized by tubulointerstitial fibrosis and tubular dedifferentiation. Tubular dedifferentiation, which is associated with the loss of epithelial markers and the gain of mesenchymal features, is thought to be involved in tubulointerstitial fibrosis. As protein kinase B/Akt is involved in the development of CKD, we investigated the role of Akt1, one of the three Akt isoforms, in a murine model of AKI-to-CKD progression. Methods: We subjected C57BL/6 male mice to unilateral ischemia-reperfusion injury (UIRI) and harvested their kidneys after 6 weeks. Mice were divided into four groups, namely, wild-type (WT) UIRI, Akt1−/− UIRI, WT sham, and Akt1−/− sham. Results: Akt1 (but not Akt2 or Akt3) was markedly activated in WT UIRI mice than in WT sham mice. Tubulointerstitial fibrosis and tubular dedifferentiation significantly increased in WT UIRI mice, but were attenuated in Akt1−/− UIRI mice. Both WT UIRI and Akt1−/− UIRI mice showed markedly upregulated transforming growth factor-β1 (TGF-β1)/Smad signaling compared with WT sham mice. However, TGF-β1/Smad expression did not differ between the two groups. The levels of phosphorylated GSK-3β, β-catenin, and Snail were attenuated in Akt1−/− UIRI mice compared with those in WT UIRI mice. Conclusions: Deletion of Akt1 results in the attenuation of renal fibrosis and tubular dedifferentiation, independent of TGF-β1/Smad signaling, during AKI-to- CKD progression in a UIRI without contralateral nephrectomy model. Thus, Akt1 may serve as a therapeutic target in AKI-to-CKD progression.
참고문헌 (29)
- Hsu RK, "Temporal changes in incidence of dialysis-requiring AKI", J Am Soc Nephrol, 24, pp.37~42 (2013)
- Chertow GM, "Acute kidney injury, mortality, length of stay, and costs in hospitalized patients", J Am Soc Nephrol, 16, pp.3365~3370 (2005)
- VA, "NIH Acute Renal Failure Trial Network", Intensity of renal support in critically ill patients with acute kidney injury, 2008, pp.359, 7~20
- Go AS, "Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization", N Engl J Med, 351, pp.1296~1305 (2004)
- Chawla LS, "Acute kidney injury and chronic kidney disease as interconnected syndromes", N Engl J Med, 371, pp.58~66 (2014)
- Tampe B, "Low-dose hydralazine prevents fibrosis in a murine model of acute kidney injury-to-chronic kidney disease progression", Kidney Int, 91, pp.157~176 (2017)
- Guzzi F, "Molecular mechanisms of the acute kidney injury to chronic kidney disease transition : an updated view", Int J Mol Sci, 20, pp.4941~ (2019)
- Liu BC, "Renal tubule injury : a driving force toward chronic kidney disease", Kidney Int, 93, pp.568~579 (2018)
- Kumar S, "Cellular and molecular pathways of renal repair after acute kidney injury", Kidney Int, 93, pp.27~40 (2018)
- Wang Y, "Proximal tubule-derived colony stimulating factor-1 mediates polarization of renal macrophages and dendritic cells, and recovery in acute kidney injury", Kidney Int, 88, pp.1274~1282 (2015)
- Liu Y, "New insights into epithelial-mesenchymal transition in kidney fibrosis", J Am Soc Nephrol, 21, pp.212~222 (2010)
- Lan A, "Potential role of Akt signaling in chronic kidney disease", Nephrol Dial Transplant, 30, pp.385~394 (2015)
- Yu H, "Akt isoforms in vascular disease", Vascul Pharmacol, 71, pp.57~64 (2015)
- Black LM, "Divergent effects of AKI to CKD models on inflammation and fibrosis", Am J Physiol Renal Physiol, 315, pp.F1107~F1118 (2018)
- Kim SS, "Enhanced expression of two discrete isoforms of matrix metalloproteinase-2 in experimental and human diabetic nephropathy", PLoS One, 12, pp.e0171625~ (2017)
- Dong Y, "Ischemic duration and frequency determines AKI-to-CKD progression monitored by dynamic changes of tubular biomarkers in IRI mice", Front Physiol, 10, pp.153~ (2019)
- Lan A, "Akt2 is involved in loss of epithelial cells and renal fibrosis following unilateral ureteral obstruction", PLoS One, 9, pp.e105451~ (2014)
- Le Clef N, "Unilateral renal ischemia-reperfusion as a robust model for acute to chronic kidney injury in mice", PLoS One, 11, pp.e0152153~ (2016)
- Rodriguez-Pena AB, "Activation of small GTPase Ras and renal fibrosis", J Nephrol, 18, pp.341~349 (2005)
- Rodriguez-Pena AB, "Activation of Erk1", 2 and Akt following unilateral ureteral obstruction, 2008, pp.74, 196~209
- Xie L, "Role of PI3-kinase", Akt signalling pathway in renal function and cell proliferation after renal ischaemia, Nephrology (Carlton), pp.2006, 11[DOI]
- Kalluri R, "The basics of epithelial-mesenchymal transition", J Clin Invest, 119, pp.1420~1428 (2009)
- Sung IlKim, "TGF-b-activated kinase-1:NewinsightsintothemechanismofTGF-b signaling andkidneydisease", Kidney Research and Clinical Practice, 31(2), pp.94~105 (2012), 대한신장학회
- Xu W, "A new role for the PI3K", Akt signaling pathway in the epithelial-mesenchymal transition, 2015, pp.9, 317~324
- Bachelder RE, "Glycogen synthase kinase-3 is an endogenous inhibitor of Snail transcription : implications for the epithelial-mesenchymal transition", J Cell Biol, 168, pp.29~33 (2005)
- Lee YJ, "Troglitazone ameliorates high glucose-induced EMT and dysfunction of SGLTs through PI3K", Akt, GSK-3β, Snail1, and β-catenin in renal proximal tubule cells, 2010, pp.298, F1263~F1275
- Kattla JJ, "Protein kinase B", Akt activity is involved in renal TGF-beta1-driven epithelial-mesenchymal transition in vitro and in vivo, 2008, pp.295, F215~F225
- Toker A, "Signaling specificity in the Akt pathway in biology and disease", Adv Biol Regul, 55, pp.28~38 (2014)
- Canaud G, "AKT2 is essential to maintain podocyte viability and function during chronic kidney disease", Nat Med, 19, pp.1288~1296 (2013)